Mark Bogart Joins B-Secur as Senior Vice President of U.S. Healthcare

Ex-AliveCor executive’s new role will focus on furthering the medical strategy of the heart health technology company

BELFAST, Northern Ireland–(BUSINESS WIRE)–B-Secur, a leader in EKG technology, today announced the appointment of Mark Bogart as its new Senior Vice President (SVP) of U.S. Healthcare helping to expand the company’s footprint in the U.S. market.

Bogart will identify, develop, and build long-term agreements with medical device and digital health companies as well as cultivate and manage customer relationships with existing partners. He will also focus on delivering the company’s medical strategy for its newly launched HeartKey® 2.0 technology.

Launched in April at Heart Rhythm 2022, HeartKey® 2.0 significantly reduces EKG signal noise, elevating EKG interpretation to new heights of efficiency and accuracy for clinicians and facilitating the trend towards greater remote cardiac monitoring. It also offers a range of FDA-cleared health algorithms and actionable wellness insights.

Mark said: “Supported by a best-in-class engineering and product development team, B-Secur is at the forefront of signal conditioning and EKG rhythm analysis.

“The opportunity to engage and bring forward HeartKey® 2.0 creates tremendous opportunities across the U.S. Medtech space and ultimately improves workflow, patient care and clinical outcomes. It’s a game changer for the industry and our physician providers.”

Bogart joins B-Secur from AliveCor where he served as a SVP of the U.S. Healthcare Division. In his previous role, he helped establish KardiaMobile® 6L in the B2B markets, validated a direct reimbursement model, and developed new sales and strategic opportunities with KOL’s, leading healthcare systems, and progressive companies in digital health. He joins B-Secur with an impressive track record of working with corporate, small, and scale-up businesses and believes the company’s new technology has the power to evolve the cardiovascular space.

B-Secur’s Chief Commercial Officer, Ben Carter said he is delighted Mark has joined the company to help grow the business in the U.S.

He said: “Since the launch of HeartKey® 2.0 we have seen a strong growing demand across our key consumer and medical customers.

“Mark brings a wealth of leadership and business experience from across the medical industry. He has worked with some of the biggest medical device and platform companies in the world and has deep medical industry knowledge. I’m excited that Mark has agreed to join B-Secur and I look forward to working with him as we continue to grow our business, especially in the U.S.”

Founded in Belfast, Northern Ireland, B-Secur employs almost 100 people across offices in the U.S., the UK and Ireland. The innovative biosensing algorithm company licences its technology to a number of medical and consumer technology customers.

For more information visit or follow us on Twitter & LinkedIn

About B-Secur

Founded in Belfast, Northern Ireland, B-Secur currently employs almost 100 people across offices in the U.S., the UK and Ireland. A leader in electrocardiogram (EKG) monitoring, we are on a mission to save and improve millions of lives each year by advancing heart health technology. We build heart health algorithms and analysis solutions that bring greater clarity to EKG interpretation. Better data and deeper insights also allow us to offer powerful, health-related features to other medical fields and non-medical sectors. As a sophisticated biosensing algorithm innovation company we partner with some of the world’s leading technology companies. Combining our expertise in EKG with decades of experience in hardware, software and material science enables our partners to significantly reduce development time to market for their next generation medical and consumer devices. For more information visit or follow @B-Secur on Twitter & LinkedIn


Media Enquiries, please contact:
Annie Campbell, B-Secur

Tel: +44 (0) 7794 505920

error: Content is protected !!